David Greenwald, Ph.D.

David Greenwald, Ph.D. is the Vice President of Business Development at Deerfield Management and serves on the Board of Directors at Advanced Medicine Partners.12 His key responsibilities and experiences include:

Professional Background

• Currently serves as Vice President of Business Development at Deerfield Management since September 20184
• Searches for new investment opportunities and supports business development for Deerfield's portfolio companies3
• Provides hands-on experience to Deerfield's academic collaborations3

Board Positions

• Board member of Advanced Medicine Partners12
• Serves on the boards of Jaguar Gene Therapy, Axovia Therapeutics, Apertura Gene Therapy, and Innervace34

Previous Roles

• Director of Business Development at Johns Hopkins Technology Ventures34
• Founder of Relay Technology Management, Inc.34
• CEO of Relay Technology Management and Director of Client Solutions for Decision Resources Group (DRG)3
• Associate Investigator at the Naval Medical Research Center34

Education

• Ph.D. from Tufts University School of Medicine, focusing on gene therapy for Retinitis Pigmentosa3
• B.S. in Cellular Biology and Molecular Genetics from the University of Maryland, College Park3

Academic Involvement

• Former adjunct faculty at Tufts University Gordon Institute and The Johns Hopkins Carey Business School3
• Lectured on Entrepreneurial Finance, Corporate Finance, and Life Science Entrepreneurial Ventures34

David Greenwald's LinkedIn username is davegreenwald.4